Ahern, Jul. 1995, The Scientist, “Reagent Kits Offer Scientists . . . ” pp. 1-5.* |
Ralston, S.H. “The genetics of osteoporosis” QJ Med 1997; 90:247-251.* |
Grant, et al., “Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene,” Nature Genetics, 14:203-205 (1996). |
Uitterlinden, A.G., et al., “A large scale population based study of the association of vitamin D receptor gene polymorphisms with bone mineral density,” J Bone Miner Res, 11:1242-8 (1996). |
Uitterlinden, et al., “Relation of alleles of the collagen type I alpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women,” New Engl J Med, 338:1016-1021 (Apr. 9, 1998). |
Uitterlinden, et al., “Sp1 binding site polymorphism in the cola1 gene is associated with BMD: the Rotterdam study,” Osteoporosis International, Abstract 6(1):124, PSu164 (1996). |
Uitterlinden, et al., “Vitamin D receptor genotype is associated with radiographic osteoarthritis at the knee,” J. Clin. Invest., 100(2):259-263 (1997). |
Morrison, N.A., et al., “Prediction of bone density from vitamin D receptor alleles,” Nature, 367:284-7 (1994). |
Cooper, G.S., Umbach, D.M., “Are vitamin D receptor polymorphisms associated with bone density?,” J Bone Miner Res, 11:1841-9 (1996). |
White, C.P., et al., “Vitamin D receptor alleles predict osteoporotic fracture risk,” Abstract, J Bone Miner Res, 9(suppll):S263 (1994). |
Houston, L.A., Grant, S.F.A., Reid, D.M., Ralston, S.H., “Vitamin D receptor polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population,” Bone, 18:249-52 (1996). |
Ralston, “The Genetics of Osteoporosis,” Q J Med, 90:247-251 (1997). |
Ralston, “Genetic Markers of Bone Metabolism and Bone Disease,” Scand J Clin Lab Invest, 57(Suppl. 227):114-121 (1997). |